Page last updated: 2024-11-12

nvc-422

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

NVC-422: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11708365
CHEMBL ID1207907
SCHEMBL ID994601
MeSH IDM0560808

Synonyms (22)

Synonym
2-(dichloroamino)-2-methyl-propane-1-sulfonic acid
CHEMBL1207907
dcdmt
aganase
nvc-422
846056-87-9
1-propanesulfonic acid, 2-(dichloroamino)-2-methyl-
cd0722
auriclosene
bkr7y95229 ,
unii-bkr7y95229
n,n-dichloro-2,2-dimethyltaurine
nvc 422
auriclosene [inn]
nvc422
DTXSID80233617
SCHEMBL994601
2-(dichloroamino)-2-methylpropane-1-sulfonic acid
DB12197
aganas
Q27274738
AKOS040750635

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The aim of this study was to show that these compounds are safe in an EpiOcular model and effective in corneas infected ex vivo."( N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.
Anderson, M; Bechrakis, NE; Debabov, D; Eitzinger, C; Hager, T; Jekle, A; Lutz, M; Nagl, M; Schmid, E; Teuchner, B; Zuck, M, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.05 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]